Anti-peptic Ulcre drug is one of various classes of drugs with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract.
This report contains market size and forecasts of Anti-Peptic Ulcer Drugs in Global, including the following market information:
Global Anti-Peptic Ulcer Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Anti-Peptic Ulcer Drugs market was valued at 8965.2 million in 2021 and is projected to reach US$ 20860 million by 2028, at a CAGR of 12.8% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Proton Pump Inhibitors (PPIs) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Anti-Peptic Ulcer Drugs include AstraZeneca, Ask-pharm, Takeda, Yangtze River Pharm, Shandong Luoxin, Huadong Medicine, Changzhou Siyao, Beijing Yuekang and Guangdong Dahua and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anti-Peptic Ulcer Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-Peptic Ulcer Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Anti-Peptic Ulcer Drugs Market Segment Percentages, by Type, 2021 (%)
Proton Pump Inhibitors (PPIs)
Potassium-Competitive Acid Blockers (P-CAB)
Antacids
H2 Antagonists
Ulcer Protective Drugs
Global Anti-Peptic Ulcer Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Anti-Peptic Ulcer Drugs Market Segment Percentages, by Application, 2021 (%)
Gastritis
Gastric Ulcers
Duodenal Ulcers
Gastroesophageal Reflux Disease (GERD)
Global Anti-Peptic Ulcer Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Anti-Peptic Ulcer Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-Peptic Ulcer Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Anti-Peptic Ulcer Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
Ask-pharm
Takeda
Yangtze River Pharm
Shandong Luoxin
Huadong Medicine
Changzhou Siyao
Beijing Yuekang
Guangdong Dahua
Xian Janssen